Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports

BACKGROUND: Identifying men for a repeat prostate biopsy is a conundrum to urologists. Risk calculators (RCs) such as the European Randomized Study of Screening for Prostate Cancer (ERSPC) RCs have been developed to predict the outcome of prostate biopsies and have been shown to improve diagnostic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnee, Pieter, Hessels, Daphne, Schalken, Jack A., Van Criekinge, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884880/
https://www.ncbi.nlm.nih.gov/pubmed/31783839
http://dx.doi.org/10.1186/s12894-019-0561-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884880/
https://www.ncbi.nlm.nih.gov/pubmed/31783839
http://dx.doi.org/10.1186/s12894-019-0561-6

Ejemplares similares